More Vaccinations, Experimental Drugs as Potential Ebola Contacts Rise

The World Health Organization predicts the number of cases in Democratic Republic of Congo will rise up to 300 by July.

Written bySukanya Charuchandra
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, DK_PHOTOSThe ongoing Ebola outbreak in Democratic Republic of Congo has claimed 25 lives as of yesterday (May 29), reports Reuters, taking the total number of cases in the country to 54. This is DRC’s ninth tussle with the hemorrhagic fever since its first appearance in 1976.

The World Health Organization (WHO) is administering ring vaccinations to people who have had suspected contact, either directly or indirectly, with an Ebola patient. This means immunizing and monitoring all the individuals who have had potential contacts with patients, 906 people so far. Of those, more than 360 contacts vaccinated before Monday, reports The New York Times. The operation began in Mbandaka, a city of more than 1 million residents, last week. The rural town of Bikoro is the second site for vaccinations, which began this Monday (May 28).

A number of experimental drugs, including antibodies and antiviral options, are also available, according to Nature. WHO is awaiting the approval of DRC’s Ministry of Health to deploy them and begin trials, reports CNN.

A 2014-2016 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control